Chemical peritonitis associated with high dialysate acetaldehyde concentrations.

BACKGROUND During the standard heat sterilization process of lactate-buffered peritoneal dialysis (PD) solutions, glucose degrades to form compounds called glucose degradation products such as acetaldehyde, formaldehyde, or glyoxal. Despite evidence that these products may be responsible for some in vitro cytotoxic effects induced by commercially available PD fluids, data on their acute or chronic effects on the human peritoneum is scarce. SUBJECTS AND METHODS This case presentation is based on an observation of 21 aseptic peritonitis cases of unknown aetiology. All cases appeared within one month in a university hospital PD unit that had a peritonitis rate of 1 episode/26 patient months and 55 active patients on CAPD. Acetaldehyde level in the bags was assayed by gas chromatography. RESULTS Twenty-one patients presented with signs of peritonitis including cloudy dialysate and abdominal tenderness with additional abdominal pain in 11 patients and vomiting in one. In all cases, cultures and Gram stains were negative for micro-organisms. Fever was not observed in any patient. Average dialysate white blood cell count was 1795/mm(3). All patients were free of intraperitoneal medication when symptoms appeared. Patients were using PD solutions from a newly established domestic production plant. Apparently all patients with symptoms of peritonitis used bags with the same lot number and the solution in the bags appeared to be darker in colour than that in bags with other lot numbers. Chemical analysis of the unused PD solution samples revealed acetaldehyde levels of 17-20 p.p. m. in bags containing darker solution, which is very high compared with the usual acetaldehyde level of 6 p.p.m. in heat-sterilized PD solutions. CONCLUSIONS Based on the above findings, we hypothesize that higher levels of acetaldehyde and possibly other glucose degradation products may have been an aetiological factor in these 21 cases of chemical peritonitis. Our observation suggests that acetaldehyde, in concentrations 3-4 times higher than the usual level in commercially available PD solutions, may induce acute sterile peritonitis in CAPD patients.

[1]  C. Holmes,et al.  Reduced Glucose Degradation Products in Bicarbonate/Lactate-Buffered Peritoneal Dialysis Solutions Produced in Two-Chambered Bags , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[2]  C. Holmes,et al.  In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. , 1996, Journal of the American Society of Nephrology : JASN.

[3]  A. Wieslander,et al.  Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. , 1996, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[4]  N. Di Paolo,et al.  Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit. , 1996, Nephron.

[5]  A. Wieslander,et al.  Are Aldehydes in Heat-Sterllized Peritoneal Dialysis Fluids Toxic in Vitro? , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  B. Holmquist,et al.  Development of Toxic Degradation Products during Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Influence of Time and Temperature , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  J. Dobbie,et al.  Serositis: Comparative Analysis of Histological Findings and Pathogenetic Mechanisms in Nonbacterial Serosal Inflammation , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  A. Wieslander,et al.  Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.

[9]  A. Douvdevani,et al.  The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  D. Oreopoulos,et al.  Toxicity of osmotic solutes on human mesothelial cells in vitro. , 1992, Kidney international.

[11]  D. Graham,et al.  Chemical Peritonitis following the Intraperitoneal Administration of Vancomycin , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  L. Gotloib,et al.  Continuous Mesothelial Injury and Regeneration during long Term Peritoneal Dialysis , 1987 .

[13]  U. Coli,et al.  Peritoneal sclerosis. Role of plasticizers. , 1987, ASAIO Transactions.

[14]  I. Henderson,et al.  Potentially Irritant Glucose Metabolites in Unused CAPD Fluid , 1986 .

[15]  J. Winchester,et al.  Frontiers in Peritoneal Dialysis , 1986, Springer Berlin Heidelberg.

[16]  J. Briggs,et al.  Sclerosing Peritonitis -The Contribution of Chlorhexidine in Alcohol , 1985 .

[17]  J. Dobbie,et al.  Ultrastructural Studies on the Peritoneum with Special Reference to Chronic Ambulatory Peritoneal Dialysis , 1981, Scottish medical journal.

[18]  A. Duwe,et al.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.

[19]  J. C. Griffin,et al.  Glucose Degradation in the Presence of Sodium Lactate During Autoclaving at 121 , 1958 .